Hybiak J - Search Results

1

KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach.

Domagała P, Hybiak J, Sulżyc-Bielicka V, Cybulski C, Ryś J, Domagała W. Domagała P, et al. Among authors: hybiak j. Pol J Pathol. 2012 Nov;63(3):145-64. doi: 10.5114/pjp.2012.31499. Pol J Pathol. 2012. PMID: 23161231 Free article. Review.

2

Concordance of KRAS mutation status between luminal and peripheral regions of primary colorectal cancer. A laser-capture microdissection-based study.

Lewandowska M, Hybiak J, Domagala W. Lewandowska M, et al. Among authors: hybiak j. Pol J Pathol. 2016 Mar;67(1):13-8. doi: 10.5114/pjp.2016.59222. Pol J Pathol. 2016. PMID: 27179269 Free article.

3

Colorectal cancers differ in respect of PARP-1 protein expression.

Sulzyc-Bielicka V, Domagala P, Hybiak J, Majewicz-Broda A, Safranow K, Domagala W. Sulzyc-Bielicka V, et al. Among authors: hybiak j. Pol J Pathol. 2012 Jun;63(2):87-92. Pol J Pathol. 2012. PMID: 22864776 Free article.

4

BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAness.

Domagala P, Hybiak J, Cybulski C, Lubinski J. Domagala P, et al. Among authors: hybiak j. Int J Cancer. 2017 Apr 1;140(7):1545-1550. doi: 10.1002/ijc.30570. Epub 2017 Jan 24. Int J Cancer. 2017. PMID: 27943282 Free article.

5

Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.

Domagala P, Hybiak J, Rys J, Byrski T, Cybulski C, Lubinski J. Domagala P, et al. Among authors: hybiak j. Oncotarget. 2016 Oct 18;7(42):68662-68673. doi: 10.18632/oncotarget.11900. Oncotarget. 2016. PMID: 27626685 Free PMC article.

6

BRCA1 and PARP1 mRNA expression during progression from normal breast to ductal carcinoma in situ and invasive breast cancer: a laser microdissection study.

Hybiak J, Domagala P, Domagala W. Hybiak J, et al. Pol J Pathol. 2018;69(4):347-355. doi: 10.5114/pjp.2018.81694. Pol J Pathol. 2018. PMID: 30786684 Free article.

7

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.

Prajzendanc K, Domagała P, Hybiak J, Ryś J, Huzarski T, Szwiec M, Tomiczek-Szwiec J, Redelbach W, Sejda A, Gronwald J, Kluz T, Wiśniowski R, Cybulski C, Łukomska A, Białkowska K, Sukiennicki G, Kulczycka K, Narod SA, Wojdacz TK, Lubiński J, Jakubowska A. Prajzendanc K, et al. Among authors: hybiak j. Int J Cancer. 2020 Mar 1;146(5):1293-1298. doi: 10.1002/ijc.32655. Epub 2019 Sep 29. Int J Cancer. 2020. PMID: 31469414 Free article.

8

Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population.

Malińska K, Deptuła J, Rogoża-Janiszewska E, Górski B, Scott R, Rudnicka H, Kashyap A, Domagała P, Hybiak J, Masojć B, Cybulski C, Kram A, Boer M, Kiedrowicz M, Lubiński J, Dębniak T. Malińska K, et al. Among authors: hybiak j. Eur J Cancer Prev. 2020 Nov;29(6):511-519. doi: 10.1097/CEJ.0000000000000633. Eur J Cancer Prev. 2020. PMID: 32976206

9

Reprogramming and transdifferentiation - two key processes for regenerative medicine.

Hybiak J, Jankowska K, Machaj F, Rosik J, Broniarek I, Żyluk A, Hilderman GC, Małecki A, Łos MJ, Urasińska E. Hybiak J, et al. Eur J Pharmacol. 2020 Sep 5;882:173202. doi: 10.1016/j.ejphar.2020.173202. Epub 2020 Jun 18. Eur J Pharmacol. 2020. PMID: 32562801 Review.

10

Aspirin and its pleiotropic application.

Hybiak J, Broniarek I, Kiryczyński G, Los LD, Rosik J, Machaj F, Sławiński H, Jankowska K, Urasińska E. Hybiak J, et al. Eur J Pharmacol. 2020 Jan 5;866:172762. doi: 10.1016/j.ejphar.2019.172762. Epub 2019 Oct 26. Eur J Pharmacol. 2020. PMID: 31669590 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page